 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Tubridy Karen L
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-06-27 Sale | 2016-06-29 4:16 pm | Eleven Biotherapeutics Inc. | EBIO | Tubridy Karen L Chief Development Officer | 4,372 | $2.08 | $9,094 | 32,753 (Direct) | View |
| 2020-02-28 Sale | 2020-03-02 7:26 pm | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 3,454 | $8.7 | $30,050 | 84,679 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-06-15 Option Award | 2016-06-17 4:19 pm | 2016-06-15 2026-02-24 | Eleven Biotherapeutics Inc. | EBIO | Tubridy Karen L Chief Development Officer | 13,344 | $0.28 | 13,344 (Direct) | View |
| 2016-07-09 Option Award | 2016-07-12 4:33 pm | 2016-07-09 2026-02-24 | Eleven Biotherapeutics Inc. | EBIO | Tubridy Karen L Chief Development Officer | 13,328 | $0.28 | 26,672 (Direct) | View |
| 2016-11-30 Option Award | 2016-12-02 4:05 pm | N/A 2026-11-30 | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 130,000 | $8.61 | 130,000 (Direct) | View |
| 2017-02-21 Option Award | 2017-02-23 4:02 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 23,000 | $0 | 36,500 (Direct) | View |
| 2017-02-21 Option Award | 2017-02-23 4:02 pm | N/A 2027-02-21 | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 36,500 | $10.14 | 36,500 (Direct) | View |
| 2018-02-28 Option Award | 2018-03-02 4:14 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 17,500 | $0 | 25,000 (Direct) | View |
| 2018-02-28 Option Award | 2018-03-02 4:14 pm | N/A 2028-02-28 | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 25,000 | $14.3 | 25,000 (Direct) | View |
| 2018-12-12 Tax Withholding | 2018-12-13 08:18 am | N/A N/A | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 11,928 | $8.94 | 30,229 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-05 4:07 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 30,000 | $0 | 45,000 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-05 4:07 pm | N/A 2029-02-28 | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 45,000 | $7.28 | 45,000 (Direct) | View |
| 2019-04-11 Disposition | 2019-04-12 4:00 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 6,075 | $7.7 | 55,324 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-02 7:26 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 30,000 | $0 | 84,679 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-02 7:26 pm | N/A 2030-02-28 | Akebia Therapeutics Inc. | AKBA | Tubridy Karen L SVP Chief Development Officer | 85,000 | $8.87 | 84,679 (Direct) | View |